To include your compound in the COVID-19 Resource Center, submit it here.

Ilaris canakinumab regulatory update

EMA’s CHMP recommended expanding the label of Ilaris canakinumab from Novartis to include

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE